Paul Kim Fulgent Genetics, Inc. (FLGT) insider trading activity

Paul Kim is CFO and Treasurer of Fulgent Genetics, Inc.. Currently has a direct ownership of 204,521 shares of FLGT, which is worth approximately $3.76 Million. The most recent transaction as insider was on Jun 02, 2023, when has been sold 1,403 shares (Common Stock) at a price of $40.3 per share, resulting in proceeds of $56,540. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 205K

2.37% 3M change

2.03% 12M change

Total Value Held $3.76 Million

PAUL KIM Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 02 2023	SELL Open market or private sale	$56,540 $40.3 p/Share	1,403 Reduced 0.61%	228,890 Common Stock
May 17 2023	SELL Open market or private sale	$44,892 $35.46 p/Share	1,266 Reduced 0.55%	230,293 Common Stock
May 03 2023	SELL Payment of exercise price or tax liability	$25,370 $29.33 p/Share	865 Reduced 0.37%	231,559 Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	$134,980 $31.85 p/Share	4,238 Reduced 1.79%	232,424 Common Stock
Feb 23 2023	SELL Payment of exercise price or tax liability	$23,452 $31.65 p/Share	741 Reduced 0.31%	236,662 Common Stock
Feb 23 2023	BUY Grant, award, or other acquisition	-	16,360 Added 6.45%	237,403 Common Stock
Feb 15 2023	SELL Payment of exercise price or tax liability	$45,546 $33.99 p/Share	1,340 Reduced 0.6%	221,043 Common Stock
Feb 03 2023	SELL Payment of exercise price or tax liability	$36,934 $36.21 p/Share	1,020 Reduced 0.46%	222,383 Common Stock
Dec 02 2022	SELL Open market or private sale	$23,070 $35.33 p/Share	653 Reduced 0.29%	223,403 Common Stock
Nov 16 2022	SELL Open market or private sale	$64,458 $35.89 p/Share	1,796 Reduced 0.8%	224,056 Common Stock
Nov 07 2022	BUY Grant, award, or other acquisition	-	77,585 Added 25.57%	225,852 Common Stock
Nov 03 2022	SELL Payment of exercise price or tax liability	$46,983 $37.89 p/Share	1,240 Reduced 0.83%	148,267 Common Stock
Sep 06 2022	SELL Open market or private sale	$27,400 $41.39 p/Share	662 Reduced 0.44%	149,507 Common Stock
Aug 17 2022	SELL Open market or private sale	$95,091 $48.89 p/Share	1,945 Reduced 1.28%	150,169 Common Stock
Aug 03 2022	SELL Payment of exercise price or tax liability	$65,951 $62.93 p/Share	1,048 Reduced 0.68%	152,114 Common Stock
Jun 02 2022	SELL Open market or private sale	$22,866 $55.1 p/Share	415 Reduced 0.27%	153,162 Common Stock
May 16 2022	SELL Open market or private sale	$63,576 $53.38 p/Share	1,191 Reduced 0.77%	153,577 Common Stock
May 03 2022	SELL Payment of exercise price or tax liability	$45,692 $56.69 p/Share	806 Reduced 0.52%	154,768 Common Stock
Mar 03 2022	SELL Open market or private sale	$25,565 $56.31 p/Share	454 Reduced 0.29%	155,574 Common Stock
Feb 28 2022	BUY Grant, award, or other acquisition	-	41,000 Added 20.81%	156,028 Common Stock
Feb 15 2022	SELL Payment of exercise price or tax liability	$73,737 $66.49 p/Share	1,109 Reduced 0.95%	115,028 Common Stock
Feb 03 2022	SELL Payment of exercise price or tax liability	$50,899 $63.15 p/Share	806 Reduced 0.69%	116,137 Common Stock
Jan 03 2022	SELL Bona fide gift	-	4,000 Reduced 3.31%	116,943 Common Stock
Dec 02 2021	SELL Open market or private sale	$51,559 $83.16 p/Share	620 Reduced 0.51%	120,943 Common Stock
Nov 19 2021	SELL Open market or private sale	$979,501 $95.44 p/Share	10,263 Reduced 7.79%	121,563 Common Stock

Also insider at

XGN

EXAGEN INC. Healthcare

Director

Paul Kim

CFO and Treasurer

Temple City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FLGT shares.

Notify only if

Value

Insider Trading

Get notified when an Fulgent Genetics, Inc. insider buys or sells FLGT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Fulgent Genetics, Inc.

Track Activities on FLGT

Account